Publications by authors named "Michael Stegemann"

Claim this Profile
O
Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis.
Andrea J Gonzales, Michelle Aleo, Sean Mahabir, James Messamore, Michael Stegemann

J Vet Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of bovine respiratory disease with a single administration of tulathromycin and ketoprofen.
Jenne De Koster, Jezaniah-Kira Tena, Michael R Stegemann

Vet Rec· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-formulation of ketoprofen with tulathromycin alters pharmacokinetic and pharmacodynamic profile of ketoprofen in cattle.
Jenne De Koster, Joseph F Boucher, Jezaniah-Kira Tena, Ronette Gehring, Michael R Stegemann

J Vet Pharmacol Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
Maria J Corral, Hilde Moyaert, Tiago Fernandes, Monica Escalada, Jezaniah Kira S Tena, Michael R Stegemann

Vet Anaesth Analg· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client-owned dogs with allergic dermatitis.
Leen Van Brussel, Hilde Moyaert, Monica Escalada, Sean P Mahabir, Michael R Stegemann

Vet Dermatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
Hilde Moyaert, Leen Van Brussel, Stasia Borowski, Monica Escalada, Sean P Mahabir, Michael R Stegemann

Vet Dermatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental infection in calves.
David J Bartram, Hilde Moyaert, Bindu H Vanimisetti, Clifford P Ramage, David Reddick, Michael R Stegemann

Vet Med Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Sallie B Cosgrove, Dawn M Cleaver, Vickie L King, Amy R Gilmer, Anne E Daniels, Michael R Stegemann

Vet Dermatol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Peter R Little, Vickie L King, Kylie R Davis, Sallie B Cosgrove, Michael R Stegemann

Vet Dermatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Caroline Gadeyne, Peter Little, Vickie L King, Nigel Edwards, Kylie Davis, Michael R Stegemann

Vet Dermatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
Sallie B Cosgrove, Jody A Wren, Dawn M Cleaver, Kelly F Walsh, Stacey I Follis, Michael R Stegemann

Vet Dermatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Sallie B Cosgrove, Jody A Wren, Dawn M Cleaver, David D Martin, Kelly F Walsh, Michael R Stegemann

Vet Dermatol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens.
Andrea T Fessler, Heike Kaspar, Cynthia J Lindeman, Michael R Stegemann, Thomas Peters

Vet Microbiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds.
Robert Six, Dawn M Cleaver, Cindy J Lindeman, Judith Cherni, Robert Chesebrough, Michael R Stegemann

J Am Vet Med Assoc· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs.
Robert Six, Judy Cherni, Robert Chesebrough, Dawn Cleaver, Cindy J Lindeman, Michael R Stegemann

J Am Vet Med Assoc· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis.
Bernard Poutrel, Michael R Stegemann, Olivier Roy, Francis Pothier, Nicola Tilt

J Dairy Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis